Septerna Insider Sells 15,000 Shares Amid Equity Transaction
Daniel D. Long, Senior Vice President of Drug Discovery at Septerna (SEPN), sold 15,000 shares following the exercise of stock options on June 22, 2026. The transaction reduced his direct ownership by approximately 13.46%, from 111,412 to 96,412 shares.
Tickers: $SEPN
Topics: executive ownership SEC filing stock options exercise